Enrofloxacin-mimic antigen epitope peptide, and preparation method and application thereof

A technology of antigenic epitopes and mimetic epitopes, which is applied in the direction of analyzing materials through chemical reactions, observing the influence of chemical indicators for material analysis, and material inspection products, etc., which can solve the immunological properties of antigenic epitope peptides Adaptability matching, difficult to obtain detection results, unclear preparation methods and other problems, to achieve high sensitivity, reduce harm to human health and ecological environment, and highlight the effect of application value

Active Publication Date: 2018-08-10
INST OF MICROBIOLOGY JIANGXI ACADEMY OF SCI
6 Cites 3 Cited by

AI-Extracted Technical Summary

Problems solved by technology

[0004] The present invention aims at the technical defects of the prior art, and provides an antigenic epitope peptide simulating enrofloxacin, so as to solve the lack of an immunoreactive peptide similar to that of enrofloxacin in the prior art and capable of replacing it. Technical Problems of Sensitive Immunoassay Detection Components
[0005] The present invention also provides a method for preparing the above-mentioned antigenic epitope peptide imitating enrofloxacin to solve the tec...
View more

Method used

Take out the strip processed through step (2), add respectively the phage (about 1.0 × 1010 pfu) of 50 μ l ENR antigen mimic epitope and the 50 μ l ENR standard substance of a series of different concentrations in every hole, hatch 45 min at 37 ℃, Wash 6 times with PBST; add 100 μl 1:5000 dilution of HRP-labeled anti-M13 phage secondary antibody, incubate at 37°C for 45 min, and wash 6 times with PBST. Add 100 μl TMB substrate for color development, and read the OD450nm absorbance value with a microplate reader. Taking the...
View more

Abstract

The invention provides an enrofloxacin-mimic antigen epitope peptide, and preparation methods and an application thereof. The ENR-mimic antigen epitope peptide having a sequence represented by GKPYITWis panned from a phage random display heptapeptide library through a phage display peptide library technology with an anti-ENR monoclonal antibody as a target. The invention respectively provides a method for preparing the antigen-mimic epitope by a phage amplification technology and a method for preparing the antigen-mimic epitope by a gene recombination technology. A concrete detection method is designed based on enzyme linked immunosorbent assay, colloidal gold immunochromatography and fluorescence microsphere immunochromatography by using the immunological binding property of the antigen-mimic epitope. The antigen-mimic epitope has similar immunoreactivity characteristics to natural ENR molecules, can be used in the immunological detection of ENR to replace an ENR standard substance having strong drug resistance and high price, and the detection result is accurate and highly-sensitive.

Application Domain

Material analysis by observing effect on chemical indicatorBiological testing

Technology Topic

MimotopeImmunosorbent method +12

Image

  • Enrofloxacin-mimic antigen epitope peptide, and preparation method and application thereof
  • Enrofloxacin-mimic antigen epitope peptide, and preparation method and application thereof
  • Enrofloxacin-mimic antigen epitope peptide, and preparation method and application thereof

Examples

  • Experimental program(7)

Example Embodiment

[0038] Example 1. Panning and identification of ENR antigen mimotope
[0039] (1) Affinity panning of ENR antigen mimotope: the specific method is: 0.1M NaHCO 3 (pH 8.6) Dilute the anti-ENR monoclonal antibody, and add the final concentration of 80μg/ml to a 96-well microtiter single well, and coat overnight at 4°C. The next day, it was quickly washed 6 times with TBST [50mM Tris-HCl (pH7.5), 150mM NaCl, 0.1% Tween-20 (v/v)], then 350μl of 1% OVA blocking solution was added and blocked at 4°C for 2h. Discard the blocking solution, wash with TBST 6 times, add 120μl of phage peptide library (phage display hepeptide library, purchased from NEB, dilute the phage with TBST, add 2.0×10 11 pfu), react at 25°C for 50 min. The phage in the well was discarded, washed 10 times with TBST, patted dry, eluted with 0.2M Glycine-HCl (pH 2.2) for 8 min, and then neutralized with 15 μl of 1M Tris-HCl (pH 9.1). Take 5μl of the eluted phage to measure the titer, and use the rest for E.coli ER2738 strain for amplification. The phage was purified with PEG/NaCl the next day, and the titer of the amplified phage was determined. In the second and third rounds of panning, the coated anti-ENR monoclonal antibody concentrations were 40 μg/ml and 20 μg/ml, respectively, the blocking solution was 1% BSA and 1% OVA, and the TBST concentration used was 0.3 % And 0.5%. In the elution mode, 0.2MGlycine-HCl (pH 2.2) was still used in the second round, and ENR standard (10ng/ml) competitive elution was used in the third round, and the remaining steps were the same as above.
[0040] (2) Identification of positive phage clones: 24 phage plaques were randomly selected from the plate where the phage titer was measured after the third round of panning for phage amplification and purification, and the purified product was purified by indirect enzyme-linked immunosorbent method. For positive identification, the specific operation is as follows: Use 0.1M NaHCO 3 (pH 8.6) Dilute the anti-ENR monoclonal antibody, coat a 96-well ELISA plate with 1μg/ml, and incubate overnight at 4°C. After washing 3 times with PBST [10mM PBS, pH7.4, 0.05% Tween-20 (v/v)] the next day, blocking with 1% BSA, blocking for 2 hours at 4°C; discarding the blocking solution, and washing 3 times with PBST; 100μl plaque purification solution (about 1.0×10 10 pfu), with the original phage peptide library as a negative control, incubate at 37°C for 45min, wash 6 times with PBST; add 100μl of HRP-labeled anti-M13 phage secondary antibody diluted 1:5000, incubate at 37°C for 45min, wash 6 times with PBST; add 100μl TMB substrate solution, protect from light for 10 minutes, read the absorbance value at 450nm with a microplate reader. Select OD 450nm Phage clones that are 2 times larger than the negative control are considered positive clones.
[0041] (3) Identification of ENR antigen mimic epitope: use indirect competitive enzyme-linked immunosorbent assay to determine the epitope of all positive phage clones, the specific operation is as follows: use 0.1M NaHCO 3 (pH 8.6) Dilute the anti-ENR monoclonal antibody, coat a 96-well ELISA plate with 1μg/ml, and incubate overnight at 4°C. After washing 3 times with PBST [10mM PBS, pH7.4, 0.05% Tween-20 (v/v)] the next day, block with 1% BSA and block for 2h at 4℃; discard the blocking solution, wash 3 times with PBST, add 50μl of positive phage clones (about 1.0×10 10 pfu) and 50μl ENR standard (10ng/ml), incubate at 37℃ for 45min, wash 6 times with PBST; add 100μl of 1:5000 diluted HRP-labeled anti-M13 phage secondary antibody, incubate at 37℃ for 45min, wash 6 times with PBST; add 100μl TMB Substrate solution, protected from light for 10 minutes, read the absorbance value at 450nm with a microplate reader. Phages that can be inhibited by ENR standard products are identified as ENR antigen mimotopes.

Example Embodiment

[0042] Example 2. Sequencing of ENR antigen mimotope coding gene and determination of its amino acid sequence
[0043] The phage identified as the mimic epitope of the ENR antigen by indirect competitive enzyme-linked immunosorbent assay was amplified, and the phage DNA was extracted. The operation process is as follows: amplify the target phage, after the amplified product is centrifuged, transfer 500μl of phage supernatant to a new centrifuge tube; add 200μl of PEG/NaCl to precipitate the phage, stand for 20min, and centrifuge at 14000rpm for 10min. The supernatant was discarded, the pellet was resuspended in 100μl of iodide buffer (10mM Tris-HCl (pH 8.0), 1mM EDTA, 4M NaI), 250μl of absolute ethanol was added for precipitation, and the pellet was allowed to stand for 15min and centrifuged at 14000rpm for 10min. After discarding the supernatant, wash the precipitate (DNA sequencing template) with 70% ethanol, centrifuge at 14000 rpm for 10 min, discard the supernatant, and briefly vacuum dry. Resuspend the pellet in 30μl TE buffer (10mM Tris-HCl (pH 8.0), 1mM EDTA), take 4μl for agarose gel electrophoresis analysis; take 10μL phage template for DNA sequencing, the -96gIII sequencing primer is: 5'- HOCCC TCA TAG TTA GCG TAA CG-3'. According to the DNA sequencing results and the codon table, the amino acid sequence of the ENR antigen mimotope can be obtained. The amino acid sequence of all plaques is GKPYITW.

Example Embodiment

[0044] Example 3. Application of ENR antigen mimotope as a competitive antigen in enzyme-linked immunoassay
[0045] (1) Sample extraction
[0046] Remove the fat and connective tissue of the pork, break it up with a blender, weigh 2g into a 15ml centrifuge tube, add 4ml of 50% methanol-PBS solution, shake on a shaker for 3min; centrifuge at 4000rpm for 10min. Repeat the above shaking and centrifugation steps for the precipitation, combine the two supernatants, centrifuge again at 10000rpm, 4℃ for 10min to collect the supernatant, filter with a microporous membrane (pore size 0.22μm), dilute the filtrate with PBS in equal volume, and mix well spare. Take 50μl of filtrate directly into the micropores for enzyme-linked immunoassay determination.
[0047] (2) Antibody coating
[0048] Use 0.1M NaHCO 3 (pH 8.6) Dilute the anti-ENR monoclonal antibody, coat the microplate with 1μg/ml, and incubate overnight at 4°C. After washing 3 times with PBST [10mM PBS, 0.05% Tween-20(v/v)] the next day, blocking with 1% BSA, blocking at 4℃ for 2h, washing the plate 3 times with PBST, pat dry, and placing it at 4℃ for use .
[0049] (3) Establishment of standard curve
[0050] Take out the slats processed in step (2), add 50μl ENR antigen mimotope phage (about 1.0×10 10 pfu) and a series of 50μl ENR standards of different concentrations, incubated at 37°C for 45 min, washed with PBST 6 times; 100μl 1:5000 diluted HRP-labeled anti-M13 phage secondary antibody was added, incubated at 37°C for 45 min, washed with PBST 6 times. Add 100μl TMB substrate for color development, read the OD with a microplate reader 450nm Absorbance value. Taking the logarithm of ENR concentration as the abscissa, the binding rate (OD 450nm / OD of holes without ENR 450nm ×100%) is the ordinate, the ENR indirect competition ELISA standard curve was established, and the results showed a good linear correlation ( figure 1 ). Such as figure 1 , Standard curve of indirect competitive enzyme-linked immunosorbent assay method established by ENR antigen mimic epitope. ENR antigen mimotope (GKPYITW) and IC of anti-ENR antibody 50 The value is 89.5 pg/ml.
[0051] (4) Testing of samples
[0052] Take out the slats processed in step (2), add 50μl ENR antigen mimotope phage (about 1.0×10 10 pfu) and the sample extract to be tested, incubated at 37°C for 45 min. Discard the reaction solution, wash with PBST 6 times; add 1:5000 diluted HRP-labeled anti-M13 phage secondary antibody, incubate at 37°C for 45 min, discard the reaction solution, wash with PBST 6 times; then use TMB substrate to develop color and read the OD 450nm Value, calculate the binding rate, and calculate the ENR content in the sample according to the standard curve.

PUM

no PUM

Description & Claims & Application Information

We can also present the details of the Description, Claims and Application information to help users get a comprehensive understanding of the technical details of the patent, such as background art, summary of invention, brief description of drawings, description of embodiments, and other original content. On the other hand, users can also determine the specific scope of protection of the technology through the list of claims; as well as understand the changes in the life cycle of the technology with the presentation of the patent timeline. Login to view more.

Similar technology patents

Human colorectal adenocarcinoma tumor cell line as well as preparation method and application thereof

ActiveCN103243074AHigh tumorigenic capacity in vivoStrong drug resistance
Owner:INST OF ZOOLOGY CHINESE ACAD OF SCI

Noise detection system and noise detection method

ActiveCN108398182ATime-saving detection processThe test result is accurate
Owner:GREE ELECTRIC APPLIANCES INC OF ZHUHAI

Classification and recommendation of technical efficacy words

  • Strong drug resistance
  • The test result is accurate

Human colorectal adenocarcinoma tumor cell line as well as preparation method and application thereof

ActiveCN103243074AHigh tumorigenic capacity in vivoStrong drug resistance
Owner:INST OF ZOOLOGY CHINESE ACAD OF SCI

Non-contact tension detection and feedback control mesh belt winding device

InactiveCN101603244AThe test result is accurateFaster and more effective tension adjustment
Owner:珠海蓝坊智能设备有限公司

Image noisy point detection method based on convolution neural network

ActiveCN103971342AImprove learning accuracyThe test result is accurate
Owner:XIAMEN MEITUZHIJIA TECH

Memory device detecting method

Owner:SHENZHEN COSHIP ELECTRONICS CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products